Yu Xia
Director at Summit Therapeutics Inc. (SMMT) since January 2023
Yu Xia has filed 6 insider reports with the SEC since January 2023, as director at Summit Therapeutics Inc. (SMMT). Yu Xia made no open-market purchases or sales in the last 12 months. The latest filing, on January 6, 2026, reports grant or award at Summit Therapeutics Inc. (SMMT).
- Filings
- 6
- Companies
- 1
- Bought on market
- $57.7M
- Sold on market
- None
Companies where Yu Xia is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince January 2023 | $57.7M | $1.80 | $9.95+453% | Jan 6, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jan 2, 2026SMMTSEC Form 4 filed by Director Xia YuForm 4Grant or award
- Oct 21, 2025+$10MSMMTDirector Xia Yu bought $9,999,983 worth of shares (533,617 units at $18.74)Form 4Open-market purchase
- Jan 2, 2025SMMTSEC Form 4 filed by Director Xia YuForm 4Grant or award
- Mar 7, 2023+$47.7MSMMTSEC Form 5 filed by Xia YuForm 5Open-market purchase
- Jan 2, 2024SMMTSEC Form 4 filed by Xia YuForm 4Grant or award
- Jan 17, 2023SMMTYu Xia became an insiderForm 3New insider
Compare Yu Xia with
- Yu Xia vs Robert W Duggan1 shared
- Yu Xia vs Mahkam Zanganeh1 shared
- Yu Xia vs Manmeet Singh Soni1 shared
- Yu Xia vs Bhaskar Anand1 shared
- Yu Xia vs Robert F. Booth1 shared
- Yu Xia vs Jeff Huber1 shared
Other insiders at the same companies
- Robert W DugganSMMT
- Mahkam ZanganehSMMT
- Manmeet Singh SoniSMMT
- Bhaskar AnandSMMT
- Robert F. BoothSMMT
- Jeff HuberSMMT
- Mostafa RonaghiSMMT
- Kenneth A ClarkSMMT
- Alessandra CesanoSMMT
Questions about Yu Xia
- What is Yu Xia's role at Summit Therapeutics Inc.?
- Yu Xia reports to the SEC as director at Summit Therapeutics Inc. (SMMT), according to the latest filing on January 6, 2026.
- Has Yu Xia bought or sold stock recently?
- The most recent open-market purchase was on October 21, 2025: bought 533,617 shares of Summit Therapeutics Inc. (SMMT) for $10M at an average of $18.74.
- How do I get alerts when Yu Xia files?
- Follow Yu Xia on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Yu Xia (SEC CIK 0001963544). Totals count each trade once, skipping amendments whose original is on file, from Jan 26, 2023 on. View on SEC EDGAR · Get this as JSON